Innov - PS General 

The Pharmaceuticals Partnerships Program is a $150 million five year competitive entry program, focused on increasing the level of high quality pharmaceuticals R&D and the number of partnerships between pharmaceuticals companies and the research sector.

Executive summary of The Pharmaceuticals Industry Action Agenda Local Priority Global Partner report. The Action Agenda is a ten year growth plan for the industry.

A discussion paper prepared as background for the development of the Pharmaceuticals Industry Action Agenda

Links to reports relating to the Pharmaceuticals Industry.

Pharmaceuticals Industry Action Agenda Benchmarking Study to compare and monitor Australia's competitive advantages against competing countries.

Executive Summary of the Pharmaceuticals Industry Action Agenda Benchmarking Study to compare and monitor Australia's competitive advantages against competing countries

The purpose of the evaluation is to assess the outcomes of the Pharmaceuticals Industry Action Agenda against industry goals and industry policy objectives of the Government.